Prostate Cancer - Results from #22080

Evolution of advanced technologies in prostate cancer radiotherapy - Abstract October 10, 2013

High level of dioxin-TEQ in tissue is associated with Agent Orange exposure but not with biochemical recurrence after radical prostatectomy - Abstract October 10, 2013

Intraductal carcinoma of the prostate: The whole story - Abstract October 10, 2013

Pathological and oncologic outcomes for men with positive lymph nodes at radical prostatectomy: The Johns Hopkins Hospital 30-year experience - Abstract October 10, 2013

Reduction in radiation-induced lymphocytopenia by famotidine in patients undergoing radiotherapy for prostate cancer - Abstract October 10, 2013

Accurate IMRT fluence verification for prostate cancer patients using 'in-vivo' measured EPID images and in-room acquired kilovoltage cone-beam CT scans - Abstract October 10, 2013

Educational benefits of Internet and computer-based programmes for prostate cancer patients: A systematic review - Abstract October 10, 2013

Clinical comparison between a currently available single-loop and an investigational dual-channel endorectal receive coil for prostate magnetic resonance imaging: A feasibility study at 1.5 and 3 T - Abstract October 10, 2013

Phase I study of ARN-509, a novel antiandrogen, in the treatment of castration-resistant prostate cancer - Abstract October 9, 2013

Robot-assisted radical prostatectomy for the treatment of radiation-resistant prostate cancer: Surgical, oncological and short-term functional outcomes - Abstract October 9, 2013

Enzalutamide as a second generation antiandrogen for treatment of advanced prostate cancer - Abstract October 9, 2013

Intraductal carcinoma of prostate: A comprehensive and concise review - Abstract October 9, 2013

A new era of testosterone and prostate cancer: From physiology to clinical implications - Abstract October 9, 2013

Effect of repeated prostate biopsies on erectile function in men under active surveillance for prostate cancer - Abstract October 9, 2013

Postoperative high-dose pelvic radiotherapy for N+ prostate cancer: Toxicity and matched case comparison with postoperative prostate bed-only radiotherapy - Abstract October 9, 2013

Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer: Early late toxicity and 3-year clinical outcome - Abstract October 9, 2013

The role of cryosurgery of the prostate for nonsurgical candidates - Abstract October 9, 2013

The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance - Abstract October 9, 2013

The use of an active appearance model for automated prostate segmentation in magnetic resonance - Abstract October 8, 2013

Ten-year outcomes of sexual function after radical prostatectomy: Results of a prospective longitudinal study - Abstract October 8, 2013

Page 1105 of 1435